JP2006501265A5 - - Google Patents

Download PDF

Info

Publication number
JP2006501265A5
JP2006501265A5 JP2004535478A JP2004535478A JP2006501265A5 JP 2006501265 A5 JP2006501265 A5 JP 2006501265A5 JP 2004535478 A JP2004535478 A JP 2004535478A JP 2004535478 A JP2004535478 A JP 2004535478A JP 2006501265 A5 JP2006501265 A5 JP 2006501265A5
Authority
JP
Japan
Prior art keywords
metabotropic glutamate
glutamate receptor
antagonist
drug
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2004535478A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006501265A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/010061 external-priority patent/WO2004024150A2/en
Publication of JP2006501265A publication Critical patent/JP2006501265A/ja
Publication of JP2006501265A5 publication Critical patent/JP2006501265A5/ja
Withdrawn legal-status Critical Current

Links

JP2004535478A 2002-09-10 2003-09-10 嗜癖および鬱病を含むmgluレセプターに関連する疾患を処置するためのmgluレセプターアンタゴニスト Withdrawn JP2006501265A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40986702P 2002-09-10 2002-09-10
PCT/EP2003/010061 WO2004024150A2 (en) 2002-09-10 2003-09-10 Mglu receptors antagonists for treating disorders associated with mglu receptors including addiction and depression

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2010113270A Division JP2010174039A (ja) 2002-09-10 2010-05-17 嗜癖および鬱病を含むmgluレセプターに関連する疾患を処置するためのmgluレセプターアンタゴニスト
JP2013231434A Division JP2014074032A (ja) 2002-09-10 2013-11-07 嗜癖および鬱病を含むmgluレセプターに関連する疾患を処置するためのmgluレセプターアンタゴニスト

Publications (2)

Publication Number Publication Date
JP2006501265A JP2006501265A (ja) 2006-01-12
JP2006501265A5 true JP2006501265A5 (cg-RX-API-DMAC7.html) 2006-10-26

Family

ID=31994019

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004535478A Withdrawn JP2006501265A (ja) 2002-09-10 2003-09-10 嗜癖および鬱病を含むmgluレセプターに関連する疾患を処置するためのmgluレセプターアンタゴニスト
JP2010113270A Pending JP2010174039A (ja) 2002-09-10 2010-05-17 嗜癖および鬱病を含むmgluレセプターに関連する疾患を処置するためのmgluレセプターアンタゴニスト
JP2013231434A Pending JP2014074032A (ja) 2002-09-10 2013-11-07 嗜癖および鬱病を含むmgluレセプターに関連する疾患を処置するためのmgluレセプターアンタゴニスト

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010113270A Pending JP2010174039A (ja) 2002-09-10 2010-05-17 嗜癖および鬱病を含むmgluレセプターに関連する疾患を処置するためのmgluレセプターアンタゴニスト
JP2013231434A Pending JP2014074032A (ja) 2002-09-10 2013-11-07 嗜癖および鬱病を含むmgluレセプターに関連する疾患を処置するためのmgluレセプターアンタゴニスト

Country Status (10)

Country Link
US (2) US8354447B2 (cg-RX-API-DMAC7.html)
EP (1) EP1539149B1 (cg-RX-API-DMAC7.html)
JP (3) JP2006501265A (cg-RX-API-DMAC7.html)
CN (2) CN1694701A (cg-RX-API-DMAC7.html)
AT (1) ATE539768T1 (cg-RX-API-DMAC7.html)
AU (1) AU2003270166A1 (cg-RX-API-DMAC7.html)
BR (1) BR0314192A (cg-RX-API-DMAC7.html)
CA (1) CA2498022C (cg-RX-API-DMAC7.html)
ES (1) ES2381664T3 (cg-RX-API-DMAC7.html)
WO (1) WO2004024150A2 (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
EP1578422B1 (en) 2002-12-20 2007-04-11 NicoNovum AB A physically and chemically stable nicotine and micorcrystalline cellulose containing particulate material
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200922566A (en) 2007-09-14 2009-06-01 Ortho Mcneil Janssen Pharm 1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
BRPI0816970A2 (pt) 2007-09-14 2015-03-24 Ortho Mcneil Janssen Pharm 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
EA017648B1 (ru) 2007-09-14 2013-02-28 Орто-Макнейл-Янссен Фармасьютикалз, Инк. 1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
CA2704436C (en) 2007-11-14 2016-01-05 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
JP5547194B2 (ja) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としての3−アザビシクロ[3.1.0]ヘキシル誘導体
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102439015B (zh) 2009-05-12 2015-05-13 杨森制药有限公司 1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途
HRP20131122T1 (hr) 2009-05-12 2013-12-20 Janssen Pharmaceuticals, Inc. Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
JP5852664B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
EP2661435B1 (en) 2010-11-08 2015-08-19 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
US8685404B2 (en) 2011-01-31 2014-04-01 Oregon Health & Science University Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
PL3096790T3 (pl) 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
KR20200035035A (ko) 2017-07-31 2020-04-01 노파르티스 아게 코카인 사용 감소 또는 코카인 사용 재발 예방에 있어서 마보글루란트의 용도
US20210393621A1 (en) 2018-10-26 2021-12-23 The Research Foundation For The State University Of New York Combination serotonin specific reuptake inhibitor and serotonin 1a receptor partial agonist for reducing l-dopa-induced dyskinesia
CN110151184A (zh) * 2019-04-19 2019-08-23 昆明依利科特科技有限公司 非接触式吸毒人员快速检测系统及方法
WO2022123482A1 (en) * 2020-12-11 2022-06-16 Novartis Ag Use of mglur5 antagonists for treating amphetamine addiction
GB202106872D0 (en) * 2021-05-13 2021-06-30 Addex Pharmaceuticals Sa Novel compounds
CN114088427A (zh) * 2021-11-22 2022-02-25 昆明理工大学 一种用于惯容器/悬架的性能测试试验台及试验方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200201023T2 (tr) * 1999-10-15 2002-09-23 F. Hoffmann-La Roche Ag Benzodiazepin türevleri.
GB0005700D0 (en) 2000-03-09 2000-05-03 Glaxo Group Ltd Therapy
US6916821B2 (en) * 2001-04-02 2005-07-12 Brown University Methods of treating disorders with Group I mGluR antagonists

Similar Documents

Publication Publication Date Title
Baldo Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity
Khatri et al. Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats.
Harrison et al. Nicotine potentiation of brain stimulation reward reversed by DHβE and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats
Warner et al. How does bupropion work as a smoking cessation aid?
Fainsinger et al. Methadone in the management of cancer pain: a review
Sutherland et al. Naltrexone, smoking behaviour and cigarette withdrawal
Balfour et al. The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?
Skjei et al. Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats
Glick et al. Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener
Cryan et al. Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion
Hart et al. Comparison of intravenous cocaethylene and cocaine in humans
JP6232184B2 (ja) 神経伝導速度改善のための方法および組成物
JP2006501265A (ja) 嗜癖および鬱病を含むmgluレセプターに関連する疾患を処置するためのmgluレセプターアンタゴニスト
Ruyle et al. Peripheral opioid receptor antagonism alleviates fentanyl-induced cardiorespiratory depression and is devoid of aversive behavior
US20060252786A1 (en) Nicotinic-opioid synergy for analgesia
US9724340B2 (en) Antitussive compositions and methods
Chen et al. Systemic morphine inhibits dorsal horn projection neurons through spinal cholinergic system independent of descending pathways
JP2008507577A (ja) 中枢神経系の障害を治療するための医薬
US5776957A (en) Nornicotine enantiomers for use as a treatment for dopamine related conditions and disease states
Smid et al. Vagal neurotransmission to the ferret lower oesophageal sphincter: inhibition via GABAB receptors
Hettes et al. Dual roles in feeding for AMPA/kainate receptors: receptor activation or inactivation within distinct hypothalamic regions elicits feeding behavior
Adinoff et al. Cocaine‐like effects of intravenous procaine in cocaine addicts
Bespalov et al. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats
JP2006519225A (ja) 依存症治療用医薬組成物
Haxhiu et al. I1-imidazoline receptors and cholinergic outflow to the airways